These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6433083

  • 1. [Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
    Inoi T, Mojamdar M, Ichihashi M, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1984 Jan; 94(1):39-43. PubMed ID: 6433083
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
    Inoi T, Mojamdar M, Ichihashi M, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
    Agrup G, Hafström L, Jönsson PE, Rorsman H.
    Lakartidningen; 1978 Dec 06; 75(49):4599-600. PubMed ID: 364213
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G, Agrup P, Andersson T, Falck B, Hansson JA, Jacobsson S, Rorsman H, Rosengren E, Rosengren AM.
    Acta Derm Venereol; 1977 Dec 06; 57(2):113-6. PubMed ID: 71802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
    Morishima T, Saito M, Fujita M, Fukada E, Hanawa S.
    Nihon Hifuka Gakkai Zasshi; 1982 Jan 15; 92(1):53-6. PubMed ID: 6804671
    [No Abstract] [Full Text] [Related]

  • 10. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Jan 15; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 11. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V, Paul E.
    Br J Dermatol; 1982 Jan 15; 106(1):53-7. PubMed ID: 6800394
    [Abstract] [Full Text] [Related]

  • 12. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
    Jimbow K, Takahashi H, Ishihara K, Hayasaka K, Kukita A, Seki Y, Ikeda S, Terakado T.
    Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):1942-9. PubMed ID: 7184382
    [Abstract] [Full Text] [Related]

  • 13. Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
    Jönsson PE, Agrup G, Arnbjörnsson E, Hafström L, Rorsman H.
    Cancer; 1980 Jan 15; 45(2):245-8. PubMed ID: 6153150
    [Abstract] [Full Text] [Related]

  • 14. [Thermochemotherapy for malignant melanoma--combined therapy of anti-tumor agents and hyperthermia in mice].
    Yamada K, Ken, Tei, Someya T, Shimada S, Ohara K, Kukita A.
    Nihon Hifuka Gakkai Zasshi; 1984 Jan 15; 94(1):1-14. PubMed ID: 6590901
    [No Abstract] [Full Text] [Related]

  • 15. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E, Graef V, Ruppel R.
    Z Hautkr; 1980 Dec 01; 55(23):1543-60. PubMed ID: 6782780
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I, Meyer JC, Seifert B, Dummer R, Flace A, Burg G.
    Cancer Res; 1997 Nov 15; 57(22):5073-6. PubMed ID: 9371505
    [Abstract] [Full Text] [Related]

  • 17. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E, Graef V, Ruppel R, Hellwich M.
    Z Hautkr; 1983 Feb 15; 58(4):262-5. PubMed ID: 6405551
    [Abstract] [Full Text] [Related]

  • 18. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T, Miyamoto H, Harada M, Makinoya T, Yamamoto M, Miyoshi Y, Komi N.
    Gan To Kagaku Ryoho; 1984 Feb 15; 11(2):327-32. PubMed ID: 6582806
    [Abstract] [Full Text] [Related]

  • 19. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D, Decaux F, Berthelot P, Kalis B, Jardillier JC, Warren L.
    Cancer Detect Prev; 1983 Feb 15; 6(1-2):303-10. PubMed ID: 6411338
    [Abstract] [Full Text] [Related]

  • 20. [Excretion of 5-S-cysteinyldopa in the urine of Japanese patients with malignant melanoma--a helpful biochemical marker for assessing the progression of disease].
    Hanawa S.
    Nihon Hifuka Gakkai Zasshi; 1983 Mar 15; 93(4):433-42. PubMed ID: 6411952
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.